ClinicalTrials.gg

Rigel Pharmaceuticals clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 28 studies whose lead sponsor is Rigel Pharmaceuticals. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 6, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Rigel Pharmaceuticals with Johnson & Johnson and Sichuan Biokin Pharmaceutical →

Pipeline: 4 programs

Each counted once: 4 with a study Rigel Pharmaceuticals leads registered in the last two years.

  • Phase 4 (approved, new studies)

The 4 programs — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Rigel Pharmaceuticals’ own registered studies; Rigel Pharmaceuticals’ own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Rigel Pharmaceuticals’ studies test, most open studies first — 4 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

2 of Rigel Pharmaceuticals’ studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. 1A
  7. M
  8. J
  9. 1J
  10. A
  11. S
  12. O
  13. N

Add all 2 to your calendar (.ics) → With an account.

All 28 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now518%Recruiting 4 · Enrolling by invitation 1
  • Completed1968%
  • Stopped early311%Withdrawn 2 · Terminated 1
  • Status unknown or other14%

Phase

  • Phase 217
  • Phase 36
  • Phase 13
  • Phase 42

Where

  • United States23
  • Canada8
  • Germany6
  • United Kingdom6
  • Italy5
  • Bulgaria5

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 414
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 226

By the year each study started; 2 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Rigel Pharmaceuticals.

  • Rigel Pharmaceuticals
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    28 studies

Studies

Recruiting first, then most recently updated. Showing 28 of 28.